SCHEMBL6500655

SCHEMBL6500655

CC(C(=O)Oc1ccccc1Cl)N1CCc2sccc2C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 3/20 0.61
ADRA2A P08913 2/20 0.61
CYP2B6 P20813 2/20 0.61
DRD1 P21728 2/20 0.61
CYP2C19 P33261 2/20 0.61
OPRM1 P35372 2/20 0.61
OPRK1 P41145 2/20 0.61
HTR2B P41595 2/20 0.61
KCNH2 Q12809 2/20 0.61
THRB P10828 1/20 0.61
NR1I2 O75469 1/20 0.61
CHRM2 P08172 1/20 0.61
HTR2A P28223 1/20 0.61
SLC6A4 P31645 1/20 0.61
P2RY12 Q9H244 1/20 0.61
GABRA1 P14867 2/20 0.51
GABRG2 P18507 2/20 0.51
GABRB3 P28472 2/20 0.51
CYP2C8 P10632 1/20 0.47
CES1 P23141 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3172892 0.99 ABCB11 (0.60) ABCB11ADRA2ACYP2B6DRD1CYP2C19
SCHEMBL27597677 0.77 ABCB11 (0.56) ABCB11ADRA2ACYP2B6DRD1CYP2C19
SCHEMBL11003363 0.77 ABCB11 (0.82) ABCB11ADRA2ACYP2B6DRD1CYP2C19
Hydrochloric Acid SCHEMBL6635562 0.76 MAPK1 (0.57) ABCB11ADRA2ACYP2B6DRD1CYP2C19
SCHEMBL6631065 0.76 ABCB11 (0.82) ABCB11ADRA2ACYP2B6DRD1CYP2C19
Clopidogrel SCHEMBL754557 0.76 ABCB11 (1.00) ABCB11ADRA2ACYP2B6DRD1CYP2C19
Clopidogrel SCHEMBL1031641 0.76 ABCB11 (1.00) ABCB11ADRA2ACYP2B6DRD1CYP2C19
Clopidogrel SCHEMBL4769 0.76 ABCB11 (1.00) ABCB11ADRA2ACYP2B6DRD1CYP2C19
Clopidogrel SCHEMBL1031319 0.76 ABCB11 (1.00) ABCB11ADRA2ACYP2B6DRD1CYP2C19
Clopidogrel SCHEMBL5567933 0.76 ABCB11 (1.00) ABCB11ADRA2ACYP2B6DRD1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004108665-A2 A PROCESS FOR PREPARATION OF CLOPIDOGREL SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2004-12-16 WO claimed
WO-2004108665-A3 A PROCESS FOR PREPARATION OF CLOPIDOGREL SUN PHARMACEUTICAL IND LTD (IN) 2005-03-24 WO disclosed
WO-2004108665-A2 A PROCESS FOR PREPARATION OF CLOPIDOGREL SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2004-12-16 WO disclosed
WO-2004108665-A2 A PROCESS FOR PREPARATION OF CLOPIDOGREL SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2004-12-16 WO disclosed
EP-1438314-A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE ALPHA-PHENYL-APLPHA(6,7-DIHYDRO-4H-THIENO 3,2-C PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES Merck Generics (UK) Limited (GB) 2004-07-21 EP disclosed
WO-2003035652-A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES MERCK GENERICS [UK] LIMITED (GB) 2003-05-01 WO disclosed
US-5036156-A Bromination, hydrolysis SANOFI (FR) 1991-07-30 US disclosed